The Russian Direct Investment Fund (RDIF) filed an application for registration of the Sputnik V vaccine in the European Union on January 29, 2021, scientific consultations with the European Medicines Agency (EMA) took place on January 19, the fund reports.
“The RDIF filed an application for registration of the Sputnik V vaccine in the European Union on January 29, 2021 and launched the process of submitting information to the EMA through the rolling review procedure”, the RDIF said in a statement.
The Fund has official confirmation from EMA that the application has been accepted. The speed of approval of the application is determined by the European regulator.
